Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Maro Ohanian

1-28 of 28 results

View this query on the Wikidata Query Service
Tyrosine kinase inhibitors in acute and chronic leukemias

scientific article published on May 1, 2012
Frontline treatment of acute myeloid leukemia in adults

scientific article published on 11 December 2016
Is acute myeloid leukemia a liquid tumor?

scientific article published on 04 February 2013
Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phase

scientific article published on 09 December 2013
Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia

scientific article published on 3 November 2014
Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach

scientific article
Sorafenib Combined with 5-azacytidine in Older Patients with Untreated FLT3-ITD Mutated Acute Myeloid Leukemia

scientific article published on 31 August 2018
Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial

scientific article published on 10 December 2018
Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia

scientific article published on 11 May 2017
Treatment options for chronic myeloid leukemia

scientific article published on March 19, 2012
MYC protein expression is an important prognostic factor in acute myeloid leukemia

scientific article published on 09 May 2018
Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin’s lymphomas

scientific article published on April 1, 2015
Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity

scientific article published on 13 March 2012
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

scientific article published on 05 September 2018
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia

scientific article published on 20 December 2018
Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial

scientific article published on 14 March 2018
Dorsal column myelopathy after intrathecal chemotherapy for leukemia

scientific article published on 22 November 2016
Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia

scientific article published on November 21, 2014
Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States

scientific article published on 10 September 2019
Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML

scientific article published on 08 October 2020
Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality

scientific article published on 16 June 2020
Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

scientific article published on 14 March 2020
The Clinical Impact of Time to Response in De Novo Accelerated-Phase Chronic Myeloid Leukemia

scientific article published on 17 June 2020
Phase I/II Study of Dasatinib in Combination with Decitabine in Patients with Accelerated or Blast Phase Chronic Myeloid Leukemia

scientific article published on 18 July 2020
Clinical Experience of Venetoclax Combinations for Relapsed/Refractory Myeloid Malignancies

scientific article published in October 2017
A heavy metal baseline score predicts outcome in acute myeloid leukemia

journal article published in 2020
Orbital extramedullary leukaemia is not a rare entity - response to Paydas

scientific article published on 14 March 2019
Venetoclax with Decitabine Versus Intensive Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis Stratified by Risk of Treatment-related Mortality

scientific article published on 02 December 2020

Paulina is supported by:

About Paulina

Help